SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
Prevention and Treatment of Pediatric HIV Infections
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
8 of
8
|
Breast Milk and In Utero HIV-1 Transmission Select for Unique Envelope Signatures
Nicholas E. Webb
University of California Los Angeles, Los Angeles, CA, United States
Impact of Option B+ on ART Uptake and Retention in Swaziland: A Stepped-Wedge Trial
Elaine J. Abrams
ICAP, Columbia University Mailman School of Public Health, New York, NY, United States
National HIV Transmission in 4-12 Week Olds in Malawi's PMTCT Option B+ Program
Sundeep K. Gupta
Centers for Disease Control and Prevention, Lilongwe, Malawi
Impact of Maternal Tenofovir Use on HIV-Exposed Newborn Bone Mineral
George K. Siberry
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD, United States
Similar Mortality With Cotrimoxazole vs Placebo in HIV-Exposed Uninfected Children
Roger L. Shapiro
Harvard School of Public Health, Boston, MA, United States
Urgent Versus Post-Stabilization ART in Hospitalized Children: A Randomized Trial
Lisa M. Cranmer
Emory University School of Medicine, Atlanta, GA, United States
Three-Year Outcomes in PMTCT-Exposed Children Switched to EFV Once Suppressed on LPVr
Pamela Murnane
Columbia University, Johannesburg, South Africa
Efavirenz Is Associated With Higher Bone Mass in South African Children With HIV
Stephen M. Arpadi
Columbia University Medical Center, New York, NY, United States
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
8 of
8
|
